| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jul―23 |
The Role and Implications of COVID-19 in Incident and Prevalent Heart Failure |
Juan Simon Rico-Mesa, Justin Haloot, B. K. Anupama, Suman Atluri, Jing Liu, Umair Khalid |
| 2 |
[GO] |
2023―Sep―04 |
Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients |
Paolo Severino, Silvia Prosperi, Andrea D’Amato, Claudia Cestiè, Vincenzo Myftari, Viviana Maestrini, et al. (+8) Lucia Ilaria Birtolo, Domenico Filomena, Marco Valerio Mariani, Carlo Lavalle, Roberto Badagliacca, Massimo Mancone, Francesco Fedele, Carmine Dario Vizza |
| 3 |
[GO] |
2023―Aug―01 |
Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies |
Elizabeth A. V. Jones |
| 4 |
[GO] |
2022―Sep―27 |
Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic |
Luke R. Gagnon, Chandu Sadasivan, Haran Yogasundaram, Gavin Y. Oudit |
| 5 |
[GO] |
2021―Apr―22 |
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation |
Gregorio Zaccone, Daniela Tomasoni, Leonardo Italia, Carlo Mario Lombardi, Marco Metra |
| 6 |
[GO] |
2021―Mar―05 |
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review |
Jonathan S. Gordon, Mark H. Drazner |
| 7 |
[GO] |
2020―Oct―06 |
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia |
Milo Gatti, Emanuel Raschi, Elisabetta Poluzzi, Cristian Martignani, Stefania Salvagni, Andrea Ardizzoni, Igor Diemberger |
|
